Alto Neuroscience (ANRO) vs CryoPort (CYRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Alto Neuroscience (ANRO) has outperformed CryoPort (CYRX) over the past year, gaining 296.0% versus a gain of 77.0%. Alto Neuroscience is the larger company by market cap ($939.1 million vs $856.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ANRO | CYRX |
|---|---|---|
| Share price | $23.93 | $16.90 |
| Market cap | $939.06M | $855.97M |
| 1-day change | +1.74% | -2.59% |
| YTD return | +32.13% | +80.73% |
| 1-year return | +295.96% | +77.04% |
| 5-year return | — | -75.31% |
| EPS (TTM) | $-2.31 | $-0.81 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $37.48 | $18.36 |
| 52-week low | $5.23 | $7.61 |
| Distance from 52-week high | -36.15% | -7.95% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +60.38% | +16.39% |
| Average volume | 540.09K | 632.63K |
| Shares outstanding | 39.24M | 50.65M |
| Employees | 68 | 684 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ANRO has outperformed CYRX by 218.9 percentage points over the past year.
About Alto Neuroscience
ANRO stock →Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company in the United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 68 employees
About CryoPort
CYRX stock →Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide.
Health Care · Biotechnology: Pharmaceutical Preparations · 684 employees
ANRO vs CYRX FAQ
Which is bigger, Alto Neuroscience or CryoPort?
Alto Neuroscience (ANRO) is larger, with a market capitalization of $939.06M compared with $855.97M for CryoPort (CYRX).
Which stock has performed better over the past year, ANRO or CYRX?
ANRO returned +295.96% over the past 12 months, compared with +77.04% for CYRX (price return, excluding dividends). Past performance does not predict future results.
Are Alto Neuroscience and CryoPort in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.